22-kD Growth hormone exclusion assay: A new approach to measurement of non-22-kD growth hormone isoforms in human blood

European Journal of Endocrinology

Volumn 135, Issue 5, 1996, Pages 573-582

  Boguszewski, Cesar L ^a   Hynsjö, Lars ^a   Johannsson, Gudmundur ^a   Bengtsson, Bengt Åke ^a   Carlsson, Lena M S ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE DERIVATIVE; HUMAN GROWTH HORMONE; MONOCLONAL ANTIBODY; RECOMBINANT GROWTH HORMONE;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; DRUG DETERMINATION; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; IMMUNOASSAY; MALE; MEASUREMENT; PRIORITY JOURNAL; TECHNIQUE;

EID: 0029856103     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1350573     Document Type: Article

References (35)

1. Baumann G. Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. Endocr Rev 1991; 12:424-49
2. Lewis UJ. Growth hormone: what is it and what does it do? Trends Endocrinol Metab 1992;3:117-21
3. Parks JS. Molecular biology of growth hormone. Acta Pediatr Scand Suppl 1989;349:127-35
4. Charrier J, Martal J. Growth hormones: polymorphism (mini review). Reprod Nutr Dev 1988;28:857-87
5. Lewis UJ, Dunn JT, Bonewald LF, Seavey BK, Vanderlaan WP. A naturally occurring structural variant of human growth hormone. J Biol Chem 1978;253:2679-87
6. Lewis UJ, Bonewald LF, Lewis LJ. The 20,000-dalton variant of human growth hormone: location of the amino acid deletions. Biochem Biophys Res Commun 1980;92:511-6
7. Singh RNP, Seavey BK, Lewis LJ, Lewis UJ. Human growth hormone peptide 1-43: isolation from pituitary glands. J Protein Chem 1983;2:525-36
8. 44-191) with enhanced diabetogenic activity. Mol Cell Endocrinol 1991;78:45-54
9. Lewis UJ, Sinha YN, Haro LS. Variant forms and fragments of human growth hormone in serum. Acta Pediatr Suppl 1994;399:29-31
10. Baumann G, Stolar MW, Amburn, K. Molecular forms of circulating growth hormone during spontaneous secretory episodes and in the basal state. J Clin Endocrinol Metab 1985; 60:1216-20
11. The International Standard for growth hormone, human; for bioassay 80/505. Holly Hill, Hampstead, UK: London National Institute for Biological Standards and Controls, 1982
12. Box GEP, Hunter WG, Hunter JS. Statistics for experimenters. New York: Wiley, 1978
13. Haaland PD. Experimental design in biotechnology. New York: Dekker, 1989
14. Cacciari, E, Tassoni P, Parisi G, Pirazzoli P, Zucchini S, Mandini M, et al. Pitfalls in diagnosing impaired growth hormone (GH) secretion: retesting after replacement therapy of 63 patients defined as GH deficient. J Clin Endocrinol Metab 1989;74:1284-9
15. Adan L, Souberbielle JC, Brauner R. Diagnostic markers of permanent idiopathic growth hormone deficiency. J Clin Endocrinol Metab 1994;78:353-8
16. Rodbard DP, Munson J, De Lean A. Radioimmunoassay and related procedures in medicine. Vol 1. Vienna: International Atomic Energy Agency, 1978:469
17. Chatelain P, Bouillat B, Cohen R, Sassolas G, Souberbielle JC, Ruitton A, et al. Assay of growth hormone levels in human plasma using commercial kits: analysis of some factors influencing the results. Acta Pediatr Scand Suppl 1990; 370:56-61
18. Celniker AC, Chen AB, Wert Jr RW, Sherman BM. Variability in the quantitation of circulating growth hormone using commercial immunoassays. J Clin Endocrinol Metab 1989; 68: 469-76
19. Kostyo JL, Skottner A, Brostedt P, Roos P, Cameron CM, Forsman A, et al. Biological characterization of purified native 20-kDa human growth hormone. Biochim Biophys Acta 1987;925:314-24
20. Lewis UJ, Markoff E, Culler FL, Hayek A, Vanderlaan WP. Biologic properties of the 20k-Dalton variant of human growth hormone: a review. Endocrinol Jpn 1987;34 Suppl 1:73-85
21. Baumann G, Shaw MA. Plasma transport of the 20,000-dalton variant of human growth hormome (20 K): evidence for a 20 K-specific binding site. J Clin Endocrinol Metab 1990;71:1339-43
22. McCarter J, Shaw MA, Winer LA, Baumann G. The 20,000 Da variant of human growth hormone does not bind to growth hormone receptors in human liver. Mol Cell Endocrinol 1990; 73:11-4
23. Baumann G, Stolar MW, Buchanan TA. Slow metabolic clearance of the 20,000-dalton variant of human growth hormone: implications for biological activity. Endocrinology 1985;117:1309-13
24. Rowlinson SW, Walters MJ, Lewis UJ, Barnard R. Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems. Endocrinology 1996;137:90-5
25. Clapp C, Weiner RI. A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells. Endocrinology 1992;130:1380-6
26. Blethen SL, Albertsson-Wikland K, Faklis EJ, Chasalow RI. Circulating growth hormone isoforms in girls with Turner's syndrome. J Clin Endocrinol Metab 1994;78:1439-43
27. Blethen SL, Chasalow FI. Evidence for the preence of increased amounts of 20,000 dalton (20 K) growth hormone (GH) in acromegaly. 70th Annu Meet Endocr Soc, 1988. Abstract 989
28. Ochoa R, Mason M, Fonseca E, Morán C, Zárate A. Distribution of growth hormone isoforms in sera from women with normal ovarian function, galactorrhea, and normoprolactinemia. Fertil Steril 1993;60:272-5
29. Warner MD, Sinha YN, Peabody CA. Potential abnormalities in molecular forms of growth hormone in schizophrenia: a pilot study. Biol Psychiatry 1993;34:487-91
30. Albertsson-Wikland K, Jansson C, Rosberg S, Novamo A. Time-resolved immunofluorometric assay of human growth hormone. Clin Chem 1993;39:1620-5
31. Cunningham BC, Jhurani P, Ng P, Wells JA. Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis. Science 1989;243:1330-6
32. Sinha YN, Jacobsen BP. Human growth hormone (hGH)-(44-191), a reportedly diabetogenic fragment of hGH, circulates in human blood: measurement by radioimmunoassay. J Clin Endocrinol Metab 1994;78:1411-8
33. Baumann G, MacCart JG, Amburn K. The molecular nature of circulating growth hormone in normal and acromegalic man: evidence for a principal and minor monomeric forms. J Clin Endocrinol Metab 1983;56:946-52
34. Schleyer M, Mayer C. Comparative analytical studies on recombinant and native human somatotropin. Biol Chem Hoppe-Seyler 1990;371:1009-14
35. Bengtsson BÅ, Brummer RM, Edén S, Bosaeus I. Body composition in acromegaly. Clin Endocrinol 1989;30:121-30